Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibrosarcoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia, Hairy Cell 1Leiomyosarcoma 1Intraocular Lymphoma 1Histiocytoma, Malignant Fibrous 1Gastrointestinal Neoplasms 1Dermatofibrosarcoma 1

Interventions

Doxorubicin 4Cyclophosphamide 4fludarabine phosphate 3Vorinostat 3Vincristine 3Etoposide 3Rituximab 2Prednisone 2Pharmacogenomic Testing 2MK 2206 2Cyclosporine 2Busulfan 2Bortezomib 2Bevacizumab 2Antilymphocyte Serum 2veliparib 1vandetanib 1temsirolimus 1tanespimycin 1siplizumab 1romidepsin 1obatoclax 1liposomal doxorubicin 1gossypol acetic acid 1ganitumab 1fludarabine 1duvelisib 1cediranib 1cc-486 1belinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphoma, Extranodal NK-T-Cell × MLN 8237 × Clear all
NCT01466881 2016-03-10

Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
42 enrolled 10 charts
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡